Topical nepafenac in the treatment of diabetic macular edema
David Callanan, Patrick WilliamsTexas Retina Associates, Arlington, TX, USAPurpose: To determine the safety and efficacy of topical nepafenac 0.1% in the treatment of diabetic macular edema.Methods: A consecutive case series was performed of patients treated with nepafenac monotherapy twice daily fo...
Guardado en:
Autores principales: | David Callanan, Patrick Williams |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abae7a7b616b4abd96dbec2d63fb594a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
por: Seenu M Hariprasad, et al.
Publicado: (2009) -
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
por: Singh R, et al.
Publicado: (2012) -
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
por: Yüksel B, et al.
Publicado: (2017) -
Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
por: Bruce I Gaynes, et al.
Publicado: (2008) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel PU, et al.
Publicado: (2015)